News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-03-04-2015
Volume11
Issue 3

Repligen Expands US Manufacturing Facility

A facility expansion adds space for production of Repligen’s tangential flow system.

 

Repligen Corp. has completed an 11,000-sq-ft expansion of its US manufacturing facility, which includes a dedicated space for the production and assembly of the company’s Alternating Tangential Flow System

The ATF System is a product line used to increase cell density and product yield during the fermentation step of the biologic drug manufacturing process. The expansion includes areas for ATF System assembly, quality control and inventory, as well as cleanroom suites for the production of single-use ATF Systems in an ISO 7 environment.

The facility upgrade also expands on areas dedicated to cell culture research and development as well as manufacturing and support of the company's ELISA test kits and its OPUS line of pre-packed chromatography columns. An additional 7,500-sq-ft feet is reserved for future expansion of the Waltham facility.

Source: Repligen Corporation

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content